SERMORELIN ACETATE 1 MG/ML INJECTABLE, Packaged in… was recalled on September 10, 2026 in cooperation with the U.S. Food and Drug Administration because lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product..
SERMORELIN ACETATE 1 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland
Lot: 07292026@12, BUD 09/12/2026; 07302026@7, BUD 09/13/2026.
Units affected: 15 mls - in patient specific syringe doses
Where it was sold: Nationwide within the U.S
Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Class II means the product might cause a temporary or medically reversible health problem; the chance of serious harm is remote.
Stop using the product. Return it to the place of purchase for a refund, or dispose of it. Contact the recalling firm with questions.
Contact: Recalling firm: Carolina Infusion, LLC
Not sure what you're entitled to? Read our guide: what to do if your product is recalled.
Always confirm details on the official notice from the U.S. Food and Drug Administration before acting.
View official notice →The recalled bicycles' front lock nut can loosen during use, causing the front wheel to dislodge or loosen over time, posing a crash hazard.
When plugged in or switched on, the lamp cord or internal wiring can smoke, melt, spark, overheat or ignite, posing a risk of serious injury from fire and burn hazards.
Failed Content Uniformity Specifications
Failed Impurities/Degradation Specifications
Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.